ArticleBritish journal of clinical pharmacology2011
Vanishing clinical psychopharmacology.
Article in British journal of clinical pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021Trial
- Quo Vadis translational neuroscience?Translational neuroscience · 2026Review
- Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?Frontiers in psychiatry · 2021Article
- Epigenetic pharmacotherapy for substance use disorder.Biochemical pharmacology · 2019Review
- How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.Frontiers in pharmacology · 2018Article
- Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.Frontiers in pharmacology · 2018Article
- Whose well-being? Common conceptions and misconceptions in the enhancement debate.Frontiers in systems neuroscience · 2014Article
- Critical neuroscience-or critical science? A perspective on the perceived normative significance of neuroscience.Frontiers in human neuroscience · 2014Article
- From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?British journal of clinical pharmacology · 2012Review
- Drugs for Alzheimer's disease.British journal of clinical pharmacology · 2012Article
- Cardiac safety, drug-induced QT prolongation and torsade de pointes (TdP).British journal of clinical pharmacology · 2012Article
- Time for clinical trials of epigenetic drugs in psychiatric disorders?British journal of clinical pharmacology · 2012Article
- Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward.Innovations in clinical neuroscienceReview
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.